Evidence-Based Complementary and Alternative Medicine / 2021 / Article / Tab 2 / Research Article
Application of Multigroup Technology in Non-Small-Cell Lung Cancer with Qi Stagnation and Blood Stasis Syndrome Table 2 A total of 38 differential metabolites were identified in this study, including 14 metabolites in negative ion mode and 24 metabolites in positive ion mode.
Number RT (min) m/z (Da) valueFC VIP Adduct Formula Compound name 1 4.09 212.0018 0.000752 0.31934 9.74487 M-H C8 H7 NO4 S Indoxyl sulfate 2 19.54 255.2324 0.011998 1.545 3.29746 M-H C16 H32 O2 Palmitic acid 3 4.08 263.1036 0.029296 0.50604 2.40863 M-H C13 H16 N2 O4 Phenylacetyl-L-glutamine 4 19.72 281.2472 0.018968 1.6259 8.45263 M-H C18 H34 O2 (11E)-Octadecenoic acid 5 17.53 277.2166 0.00647 1.7695 5.45746 M-H C18 H30 O2 (6Z,9Z,12Z)-Octadecatrienoic acid 6 15.77 299.2594 0.011316 1.5535 1.449 M-H C18 H36 O3 (R)-10-Hydroxystearate 7 13.9 271.228 0.008923 1.6475 1.6999 M-H C16 H32 O3 16-Hydroxypalmitate 8 14.78 297.2434 0.01004 1.8186 3.22444 M-H C18 H34 O3 18-Hydroxyoleate 9 14.48 295.228 0.014379 1.7213 1.66762 M-H C18 H32 O3 9(10)-EpOME 10 13.86 295.2284 0.00243 1.658 1.28566 M-H C18 H32 O3 13-HODE 11 6.24 653.2632 0.012589 1.7245 4.57453 M-H C36 H38 N4 O8 Coproporphyrin III 12 18.58 279.2312 0.004448 1.5613 13.3247 M-H C18 H32 O2 Linoleate 13 20.9 283.2648 0.008692 1.5262 1.27355 M-H C18 H36 O2 Octadecanoic acid 14 7.83 201.1134 0.0214 1.6643 1.00239 M-H C10 H18 O4 Sebacic acid 15 19.37 317.2474 0.030716 0.58057 4.42563 M + H C21 H32 O2 5α -Pregnane-3,20-dione 16 4.17 265.1179 0.018487 0.40271 4.31748 M + H C13 H16 N2 O4 Phenylacetylglutamine 17 14.79 281.2474 0.015381 1.6879 2.37695 M + H C18 H32 O2 β -Linoleic acid18 19.94 309.2791 0.003259 1.6437 2.33255 M + H C20 H36 O2 Eicosadienoic acid 19 20.45 401.3418 0.04793 0.63495 2.25178 M + H C27 H44 O2 7-Ketocholesterol 20 4.18 134.0596 0.0004 0.31355 2.05813 M + H C8 H7 NO Indoxyl 21 21.67 297.2424 0.012856 1.5015 1.91806 M + H C18 H32 O3 18-Oxooleate 22 20.72 315.2535 0.013926 1.8311 1.81478 M + H C18 H34 O4 (8E,10S)-10-Hydroperoxyoctadeca-8-enoate 23 13.36 287.2217 0.002671 1.9422 1.50515 M + H C16 H30 O4 Hexadecanedioate 24 15.11 315.2539 0.001583 2.062 1.47203 M + H C18 H34 O4 9,10-DHOME 25 15.53 297.2433 0.002945 1.6887 1.40775 M + H C18 H32 O3 9(10)-EpOME 26 14.22 313.2379 0.010082 1.5503 1.36518 M + H C18 H32 O4 (9Z,11 E)-(13S)-13-Hydroperoxyoctadeca-9,11-dienoic acid 27 14.79 299.2581 0.005956 1.7695 1.301 M + H C18 H34 O3 cis-9,10-Epoxystearic acid 28 19.37 285.2216 0.031826 0.63012 1.23636 M + H C20 H28 O Retinal 29 13.86 297.2427 0.000278 1.7256 1.05818 M + H C18 H32 O3 13-HODE 30 11.96 447.3107 0.022674 0.59386 1.04682 M + H C27 H42 O5 3-Dehydro-2-deoxyecdysone 31 6.18 160.0756 0.001919 0.5921 1.04347 M + H C10 H9 NO Indole-3-acetaldehyde 32 15.53 319.2255 0.007767 1.7745 1.02064 M + H C20 H30 O3 Leukotriene A4 33 13.9 255.2319 0.003714 1.6028 0.993851 M + H C16 H30 O2 (9Z)-Hexadecenoic acid 34 12.57 267.1955 0.006426 1.7148 0.882565 M + H C16 H26 O3 Tetranor 12-HETE 35 17.74 451.3423 0.016417 1.5795 0.807997 M + H C27 H46 O5 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate 36 8.72 191.1065 0.02261 1.7698 0.675408 M + H C12 H14 O2 Propyl cinnamate 37 17.86 317.2692 0.016669 1.5145 0.667866 M + H C18 H36 O4 9,10-Dihydroxystearate 38 13.36 223.2056 0.001659 1.6801 0.580941 M + H C15 H26 O Farnesol